By Nigam Arora & Dr. Natasha Arora
Ratings
The ETF of choice is KWEB. Both short term and medium term ratings are being upgraded to 🔒 (To see the locked content, please take a 30 day free trial). The long term rating is 🔒.
Better Value
Chinese internet stocks have been decimated. By many measures, Chinese internet stocks provide a better value than US internet stocks. Of course, no one should underestimate the risk of China.
A Major Event
There is a major event that may change the sentiment towards Chinese internet stocks.
BABA is a Chinese e-commerce giant. People’s Bank of China (PBOC) has accepted the application of Ant Group to set up a financial holding company. Ant is a fintech giant and an affiliate of BABA.
Debacle
From a macro perspective, the debacle in Chinese internet stocks started in November 2020 when Chinese authorities forced Ant to pull the IPO. The IPO was set to raise $37B and was set to be the world’s largest IPO listing. The trigger was a speech by the founder Ma accusing authorities of stifling innovation
Zone
The buy zone is 🔒. A wide buy zone is needed because of significant volatility. Consider scaling in. See the Trade Management Guidelines to learn about scaling in.
This post was just published on ZYX Emerging Markets ETF Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
